Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-09-04 to 2025-09-05
Current total value of award: $2121.84
Description: 4569432906!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML